REGENERON PHARMACEUTICALS, INC. Investing Cash Flow 2008-2026 | REGN
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is REGENERON PHARMACEUTICALS, INC.'s current investing cash flow?
REGENERON PHARMACEUTICALS, INC. (REGN) annual investing cash flow for 2025 was $-629.1M, a 74.51% increase from 2024. REGENERON PHARMACEUTICALS, INC. investing cash flow for the quarter ending March 31, 2026 was $-428.9M.
What was REGENERON PHARMACEUTICALS, INC.'s investing cash flow in 2024?
REGENERON PHARMACEUTICALS, INC. annual investing cash flow for 2024 was $-2.47B, a 22.51% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s investing cash flow in 2023?
REGENERON PHARMACEUTICALS, INC. annual investing cash flow for 2023 was $-3.19B, a 15.84% increase from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-70.6M
→
FY2025
$-629.1M
080910111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-629.1M | +74.5% | 10-K |
| FY2024 | $-2.47B | +22.5% | 10-K |
| FY2023 | $-3.19B | +15.8% | 10-K |
| FY2022 | $-3.78B | +29.7% | 10-K |
| FY2021 | $-5.38B | -7527.1% | 10-K |
| FY2020 | $-70.6M | +96.5% | 10-K |
| FY2019 | $-2.03B | -38.6% | 10-K |
| FY2018 | $-1.46B | -45.5% | 10-K |
| FY2017 | $-1.01B | +4.0% | 10-K |
| FY2016 | $-1.05B | -15.3% | 10-K |
| FY2015 | $-907.6M | -115.7% | 10-K |
| FY2014 | $-420.8M | -18.4% | 10-K |
| FY2013 | $-355.5M | -338.4% | 10-K |
| FY2012 | $-81.1M | -163.1% | 10-K |
| FY2011 | $128.5M | +129.4% | 10-K |
| FY2010 | $-437.0M | -20245.9% | 10-K |
| FY2009 | $-2.1M | -107.0% | 10-K |
| FY2008 | $30.8M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →